For the quality and safety control of therapeutic cell products, different approaches need to be established based on product risk characteristics and specialized control measures to address products with distinct process and technological routes.
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies.
Visit our cookie policy to learn more.